Can the reality match the hype that’s jumped the rails? Midjourney Medical is a new company (or division) that grew out of Midjourney, a organization claiming to be a “community-funded lab of 60 ...

This week’s Big Data Breach affects 1.4 million patients at multiple healthcare organizations. The vector was a business associate, Xsolis, that is a vendor of utilization and case management software ...

An interesting follow up on last month’s rampant speculation of an Oracle Health sale. Bloomberg News’ Brody Ford broke the news coursing through Reddit’s Oracle threads last week about the departure ...

The long Masimo drama has a Hollywood Ending, at least for shareholders. The sale announced on Tuesday 17 February is a rich one–$180 per share, cash. (Masimo was trading in the ~$130/share range last ...

Even Oracle can’t get all the money it wants for AI. The speculation has been building since late last week, kicked off by a report from financial analyst TD Cowen that percolated through financial ...

While SpaceX has debuted to well over a $2.3 trillion (that’s with a T) market cap, it seems that even giant companies are still facing expensive headwinds. To Reuters and to Business Insider, an ...

The hottest doctor reference source withdrew its medical evidence and decision support app from the UK and European markets. The news, reported in HIStalk on 28 April, is shocking–but not surprising.

Hinge Health now public. Today (22 May) Hinge Health debuts as HNGE on the NYSE, the first big IPO for healthcare tech in two years. Last night, the virtual MSK/physical therapy provider raised $437.3 ...

A slower news week preceding the Memorial Day holiday in the US and the UK late May bank holiday. Federal budgets for 2027 are in the Congressional washing machine, and the cycle is on ‘agitate’. VA ...

The speculation is now “official”, since it is by a London investment banking firm, but it confirms this Editor’s earlier view: Oracle, to become an “AI Infrastructure Landlord” (in their apt term), ...

Why the years between today and post-AGI abundance will be the hardest political and economic problem of our generation, and why we can’t skip past them This is the longer of the two essays that ...